Catalyst Wire Dossier Catalyst Wire Dossier

erythropoietic stimulating therapy (ESA)

erythropoietin-stimulating agent · Ortho Biotech Products, L.P.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for erythropoietic stimulating therapy (ESA), covering 2014-06-30 to 2014-06-30. Get the full timeline:

Most recent: Clinical Trial Update: Dosing and Outcomes Study of Erythropoietic Stimulating Therapies in Patients With Chemotherapy Induced Anemia

See pricing